MedPath

Evaluation of the Usability and Pharmaeconomy of the MicroTech Insulin Pump System

Phase 4
Recruiting
Conditions
Diabetes type 1 and 2
Registration Number
DRKS00033431
Lead Sponsor
MicroTech Medical (Hangzhou) Co. Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Patients on insulin pump treatment (CSII, 100 patients)
Patients on insulin treatment (20 patients, Germany only)
HbA1c < 9.0 %
Subjects who are able to complete informed consent form (by him-/herself or by his/her guardian)

Exclusion Criteria

Hypoglycemia unawareness
Pregnancy
Nursing mothers
Any reason for not being able to comply with the protocol.
Serious disease or illness

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Treatment efficacy (HbA1c and hypoglycemia frequency)
Secondary Outcome Measures
NameTimeMethod
Pharmacoeconomic aspects (treatment costs)<br>Safety aspects (AEs and ADEs) <br>Environmental aspects (waste reduction)
© Copyright 2025. All Rights Reserved by MedPath